1. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus Statement on Inpatient Diabetes and Glycemic Control. Endocr Pract. 2006;12:458–468.
2. American Board of Internal Medicine Foundation Stepping Up to the Plate Alliance. Available at: http://www.abimfoundation.org/quality/suttp.shtm. Accessed November 2007.
3. National Transitions of Care Coalition. Available at: http://www.ntocc.org. Accessed November 2007.
4. JCAHO 2008 National Patient Safety Goals. Available at:
http://www.jointcommission.org/PatientSafety/National
PatientSafetyGoals/08_hap_npsgs.htm. Accessed November
2007.
5. Diabetes Control and Complications Trial Research Group.
The effect of intensive treatment of diabetes on the development
and progression of long-term complications in
insulin-dependent diabetes mellitus. N Engl J Med. 1993;
329:977–986.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive
blood-glucose control with sulphonylureas or insulin compared
with conventional treatment and risk of complications
in patients with type 2 diabetes: UK Prospective
Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–853.
7. Van Den Berghe G, Wouters P, Weekers F, et al., Intensive
insulin therapy in critically ill patients. N Engl J Med. 2001;
345:1359–1367.
8. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic
state at admission: important risk marker of mortality
in conventionally treated patients with diabetes
mellitus and acute myocardial infarction: long-term results
from the Diabetes and Insulin-Glucose Infusion in Acute
Myocardial Infarction (DIGAMI) study. Circulation. 1999;
99:2626–2632.
9. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC.
Relationship of early hyperglycemia to mortality in trauma
patients. J Trauma. 2004;56:1058–1062.
10. Thomas MC, Mathew TH, Russ GR, Rao MM, Moran J.
Early peri-operative glycaemic control and allograft rejection
in patients with diabetes mellitus: a pilot study. Transplantation.
2001;72:1321–1324.
11. Weiser MA, Cabanillas ME, Konopleva M, et al. Relation
between the duration of remission and hyperglycemia in
induction chemotherapy for acute lymphocytic leukemia
with a hyperfractionated cyclophosphamide, vincristine,
doxorubicin and dexamethasone/methotrexate cytarabine
regimen. Cancer. 2004;100:1179–1185.
12. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC.
Stress hyperglycemia and prognosis of stroke in nondiabetic
and diabetic patients: a systematic overview. Stroke.
2001;32:2426–2432.
13. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Sorensen
HT, Schonheyer HC. Diabetes and outcome of community-
acquired pneumococcal bacteriemia. Diabetes Care.
2004;27:70–76.
14. Pomposelli JJ, Baxter JK 3rd, Babineau TJ. Early postoperative
glucose control predicts nosocomial infection rate in
diabetic patients. JPEN J Parenter Enteral Nutr. 1998;22:
77–81.
15. Vriesendorp TM, Morelis QJ, DeVries JH, Legemate DA,
Hoekstra JB. Early post-operative glucose levels are an independent
risk factor for infection after peripheral vascular
surgery. A retrospective study. Eur J Vasc Endovasc Surg.
2004;28:520–525.
16. American Diabetes Association. Standards of medical care
in diabetes, 2006. Diabetes Care. 2006;29(suppl 1):s4–
s42.
17. American College of Endocrinology Task Force on Inpatient
Diabetes and Metabolic Control. American College of Endocrinology
Position Statement on Inpatient Diabetes and
Metabolic Control. Endocr Pract. 2004;10:77–82.
18. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive
insulin therapy in the medical ICU. N Engl J Med. 2006;
354:449–461
19. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin
therapy and pentastarch resuscitation in severe sepsis. N
Engl J Med. 2008;358(2):125–139.
20. Schnipper JL, Barsky EE, Shaykevich S, Fitzmaurice G, Pendergrass
ML. Inpatient management of diabetes and
hyperglycemia among general medicine patients at a large
teaching hospital. J Hosp Med. 2006;1:145–150.
21. Cook CB, Castro JC, Schmidt RE, et al., Diabetes care in
hospitalized noncritically ill patients: More evidence for
clinical inertia and negative therapeutic momentum. J
Hosp Med. 2007;2:203–211.
22. Queale WS, Seidler AJ, Brancati FL. Glycemic control and
sliding scale insulin use in medical inpatients with diabetes
mellitus. Arch Intern Med. 1997;157:545–552.
23. Campbell KB, Braithwaite SS. Hospital management of
hyperglycemia. Clin Diabetes. 2004;22:81–88.
24. Clement S, Braithwaite SS, Magee MF, et al. Management
of diabetes and hyperglycemia in hospitals. [Erratum
appears in Diabetes Care. 2005;28:1990. Dosage error in
text]. Diabetes Care. 2004;27:553–591.
25. Gunton JE, McElduff A. Hemoglobinopathies and HbA(1c)
measurement. Diabetes Care. 2000;23(8):1197–1198.
26. Schnedl WJ, Krause R, Halwachs-Baumann G, Trinker M,
Lipp RW, Krejs GJ. Evaluation of HbA1c determination
methods in patients with hemoglobinopathies Diabetes
Care. 2000;23(3):339–344.
27. Maynard G, Wesorick D, O’Malley CW, Inzucchi S. Subcutaneous
insulin order sets and protocols: effective design
and implementation strategies. J Hosp Med. 2008;3.
Transitions in Inpatient Hyperglycemia / O’Malley et al. S63
28. Wesorick D, O’Malley CW, Rushakoff R, Larsen K, Magee M. Management of diabetes and hyperglycemia in the hospital:
a practical guide to subcutaneous insulin use in the non-critically ill, adult patient. J Hosp Med. 2008;3.
PMID:8675920.
29. Bode BW, Steed RD, Schleusener DS, Strange P. Switch to multiple
daily injections with insulin glargine and insulin lispro
from continuous subcutaneous insulin infusion with insulin
lispro: a randomized, open-label study using a continuous
glucose monitoring system. Endocr Pract. 2005;11: 157–164.
30. SBAR technique for communication: a situational briefing
model. Available at: http://www.ihi.org/IHI/Topics/
PatientSafety/SafetyGeneral/Tools/SBARTechniqueforCommu
nicationASituationalBriefingModel.htm. Accessed December
2007.
31. Yates G. Promising quality improvement initiatives: reports
from the field. AHRQ Summit—Improving Health Care
Quality for All Americans: Celebrating Success, Measuring
Progress, Moving Forward 2004. Available at: http://www.
ahrq.gov/qual/qsummit/qsummit4.htm##sentara. Accessed
December 2007.
32. Braithwaite SS, Buie MM, Thompson CL, et al. Hospital
hypoglycemia: not only treatment but also prevention.
Endocr Pract. 2004;10(suppl 2):89–99.
33. American Association of Clinical Endocrinologists Inpatient
Glycemic Control Resource Center. Available at: http://
resources.aace.com/PDF/Section_05-Final-Inpatient_Non-
ICU/Hyperglycemia_Non-ICU_Protocols/Transition_from_
Intravenous_to_Subcutaneous_Insulin.PDF. Accessed November
2007.
34. Recommendations for safe use of insulin in hospitals.
American Society of Health System Pharmacists and the
Hospital and Health System Association of Pennsylvania.
2005. Available at: http://www.premierinc.com/safety/
safety-share/01–06-downloads/01-safe-use-insulin-ashp.pdf.
Accessed December 2007.
35. O’Malley CW, Emanuele MA, Maynard G, for the Society of
Hospital Medicine Glycemic Control Taskforce. Glycemic control
resource room: improving reliability of care across transitions<
and in the perioperative setting. Available at: http://
www.hospitalmedicine.org/ResourceRoomRedesign/html/
07Layer_Inter/06_Transitions.cfm. Accessed August 2008.
36. ACE/ADA Task Force on Inpatient Diabetes American College
of Endocrinology and American Diabetes Association
Consensus Statement on Inpatient Diabetes and Glycemic
Control: a call to action. Diabetes Care. 2006;29:1955–1962.
37. Schmeltz LR, DeSantis AJ, Schmidt K, et al. Conversion of
intravenous insulin infusions to subcutaneously administered
insulin glargine in patients with hyperglycemia.
Endocr Pract. 2006;12:641–650.
38. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous
insulin infusion therapy: indications, methods, and
transition to subcutaneous insulin therapy. Endocr Pract.
2004;10(suppl 2):71–80.
39. DeSantis AJ, Schmeltz LR, Schmidt K, et al. Inpatient management
of hyperglycemia: the northwestern experience.
Endocr Pract. 2006;12(5):491–505.
40. American Diabetes Association. Position statement: standards
of medical care in diabetes-2007. Diabetes Care.
2007;30(suppl 1):S4–S41.
41. American Association of Clinical Endocrinologists Inpatient
Glycemic Control Resource Center. Available at:
http://resources.aace.com/PDF/Section_05-Final-Inpatient_
Non-ICU/Hyperglycemia_Non-ICU_Protocols/Pre-Operative_
Instructions_for_Patients_with_Diabetes.PDF Accessed November
2007.
42. Nathan DM, Buse JB, Davidson MB, et al. Management of
hyperglycemia in type 2 diabetes: a consensus algorithm
for the initiation and adjustment of therapy: a consensus
statement from the American Diabetes Association and the
European Association for the Study of Diabetes. Diabetes
Care. 2006;29:1963–1972.
43. Nathan DM, Buse JB, Davidson MB, et al. Management of
hyperglycemia in type 2 diabetes: a consensus algorithm
for the initiation and adjustment of therapy: update regarding
thiazoladinediones. Diabetes Care. 2008;31:173– 175.
44. American Association of Clinical Endocrinologists Inpatient
Glycemic Control Resource Center. Challenges in Effective
Discharge Planning for Hospitalized Patients with Diabetes.
Available at: http://resources.aace.com/PDF/Section_07-
Final-Transition-Inpatient_to_Outpatient/Challenges_in_
Effective_Discharge_for_Diabetes_Patients.PPT. Accessed
December 2007.
45. Raskin P, Allen E, Hollander P. Initiating insulin therapy in
type 2 diabetes: a comparison of biphasic and basal insulin
analogs. Diabetes Care. 2005;28:260–265.
46. Holman RR, Thorne KI, Farmer AJ, et al. Addition of biphasic,
prandial, or basal insulin to oral therapy in type 2 diabetes.
N Engl J Med. 2007;357:1716–1730.
47. Mooradian AD, Bernbaum M, Albert SG. Narrative review:
a rational approach to starting insulin therapy. Ann Intern
Med. 2006;145:125–134.
48. Hirsch IB, Bergenstal RM, Parkin CG, Wright E, Buse JB. A
real-world approach to insulin therapy in primary care
practice. Clin Diabetes. 2005;23:78–86.
49. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas
and serious hypoglycemia in older persons. J
Am Geriatr Soc. 1996;44:751–755.
50. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and
risk factors for serious hypoglycemia in older persons
using insulin or sulfonylureas. Arch Intern Med. 1997;
157(15):1681–1686.
51. Heine RJ, Van Gaal LF, Johns D, et al. Exenatide versus insulin
glargine in patients with suboptimally controlled type
2 diabetes: a randomized trial. Ann Intern Med. 2005;143:
559–569.
52. Braithwaite SS. The transition from insulin infusions to
long-term diabetes therapy: the argument for insulin
analogs. Semin Thorac Cardiovasc Surg. 2006;18:366–378.
53. Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R.
ATLANTUS Study Group. Improvement of glycemic control
in subjects with poorly controlled type 2 diabetes. Diabetes
Care. 2005;28:1282–1288.
54. Riddle M, Rosenstock J, Gerich J. Investigators Insulin Glargine
4002 Study. The Treat-to Target trial: randomized
addition of glargine or human NPH insulin to oral therapy
of type 2 diabetes patients. Diabetes Care. 2003;26:
3080–3086.
55. American Association of Clinical Endocrinologists Inpatient
Glycemic Control Resource Center. Available at: http://
resources.aace.com/PDF/Section_07-Final-Transition-
Inpatient_to_Outpatient/Effective_Discharge_Planning->
Sample_Discharge_Plans/Inpatient_Diabetes_Discharge
Prescription.PDF. Accessed November 2007.
56. American Diabetes Association. Diagnosis and classification
of diabetes mellitus. Diabetes Care. 2007;30(suppl):
S42–S47.
57. Greci LS, Kailasam M, Malkani S, et al. Utility of HbA1c
levels for diabetes case finding in hospitalized patients
with hyperglycemia. Diabetes Care. 2003;26:1064–1068.
58. Mensing C, Boucher J, Cypress M, et al. National standards
for diabetes self-management education. Diabetes Care.
2006;29(suppl 1):S78–S85.
59. Society of Hospital Medicine Glycemic Control Task Force.
Workbook for improvement: improving glycemic control,
preventing hypoglycemia and optimizing care of the inpatient
with diabetes and hyperglycemia. page 105. Available at:
http://www.hospitalmedicine.org/ResourceRoomRedesign/
pdf/GC_Workbook.pdf. Accessed December, 2007.
60. Joslin Diabetes Center. EZ Start Patient Information Handouts.
Available at: http://www.joslin.org/ezstart. Accessed
December 2007.
61. Kripalani S, Jackson AT, Schnipper JL, Coleman EA. Promoting
effective transitions of care at hospital discharge: a
review of key issues for hospitalists. J Hosp Med. 2007;2:
314–323.
62. Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah
P, Baker DW. Deficits in communication and information
transfer between hospital-based and primary care physicians:
implications for patient safety and continuity of
care. JAMA. 2007;297:831–841.
63. Society of Hospital Medicine On-line Clinical Tools. Ideal
discharge for the elderly patient: a hospitalist checklist.
Available at: http://www.hospitalmedicine.org/AM/Template.
cfm?Section5QI_Clinical_Toolsemplate5/CM/ContentDisplay.
cfmContentID510303. Accessed December 2007.
64. Wheeler K, Crawford R, McAdams D, et al. Inpatient to
outpatient transfer of care in urban patients with diabetes:
patterns and determinants of immediate post-discharge
follow-up. Arch Intern Med. 2004;164:447–453.
65. Wheeler K, Crawford R, McAdams D, Robinson R, Dunbar
VG, Cook CB. Inpatient to outpatient transfer of diabetes
care: perceptions of barriers to postdischarge follow-up in
urban African American patients. Ethn Dis. 2007;17: 238–243.